|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/14 | |
| A61P 31/04 |
| (11) | Patento numeris | 2195004 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08830916.6 |
| Europos patento paraiškos padavimo data | 2008-09-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-06-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-04-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/075949 |
| Data | 2008-09-11 |
| (87) | Numeris | WO 2009/036121 |
| Data | 2009-03-19 |
| (30) | Numeris | Data | Šalis |
| 971766 P | 2007-09-12 | US |
| (72) |
WILCOX, Mark Harvey, GB
BAINES, Simon, GB
LEHOUX, Dario, CA
PARR, Thomas R., US
|
| (73) |
The Medicines Company,
8 Sylvan Way, Parsippany, NJ 07054,
US
|
| (54) | METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN |
| METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN |